Table 2.
Placebo | VL | Difference in Amount of Change from the Baseline | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
PPS n = 46 | PPS n = 45 | |||||||||
LS Mean | 95% CI | LS Mean | 95% CI | Difference | 95% CI | p-Value | ||||
Axial length | ||||||||||
PPS | ||||||||||
first visit (baseline) | 24.54 | 24.31 | 24.77 | 24.63 | 24.4 | 24.87 | ||||
24 months | 25.30 | 25.07 | 25.53 | 25.36 | 25.13 | 25.59 | ||||
change from baseline | 0.76 | 0.71 | 0.81 | 0.73 | 0.68 | 0.78 | −0.03 | −0.10 | 0.04 | 0.381 |
SER | ||||||||||
PPS | ||||||||||
first visit (baseline) | −2.73 | −2.97 | −2.49 | −2.96 | −3.2 | −2.71 | ||||
24 months | −4.26 | −4.56 | −3.96 | −4.38 | −4.68 | −4.08 | ||||
change from baseline | −1.53 | −1.73 | −1.33 | −1.42 | −1.62 | −1.23 | 0.11 | −0.17 | 0.39 | 0.434 |
VL group: violet light-transmitting eyeglasses group; LS mean: least squares mean; 95% CI: 95% confidence interval.; SER: spherical equivalent refraction under accommodative paralysis; PPS: per protocol set. Linear mixed model: variable factors are “individuals,” repeated effects are left and right sides of the participants’ eyes, intervention contents are groups wearing normal glasses and violet light-transmitting glasses, fixed effects are interactions of intervention contents and time.